Liquidia Corp. (LQDA)
36.41
-0.95
(-2.54%)
USD |
NASDAQ |
Mar 20, 16:00
36.39
-0.02
(-0.05%)
After-Hours: 20:00
Liquidia Research and Development Expense (Quarterly) : 16.72M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.26M |
| Indivior Pharmaceuticals, Inc. | 17.00M |
| Lexicon Pharmaceuticals, Inc. | 11.20M |
| Kura Oncology, Inc. | 64.41M |
| Viemed Healthcare, Inc. | 0.598M |